First cloned human immortalized adipose derived mesenchymal stem-cell line with chimeric SS18-SSX1 gene (SS-iASC).

[1]  Takuro Nakamura,et al.  Modeling Alveolar Soft Part Sarcoma Unveils Novel Mechanisms of Metastasis. , 2017, Cancer research.

[2]  C. Fletcher,et al.  Epigenetic regulation of SMARCB1 By miR‐206, ‐381 and ‐671‐5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR‐765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas , 2016, Genes, chromosomes & cancer.

[3]  P. Schöffski,et al.  Biology and management of clear cell sarcoma: state of the art and future perspectives , 2016, Expert review of anticancer therapy.

[4]  Li Ding,et al.  The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis , 2016, Oncogene.

[5]  U. Vogel,et al.  Utility of characteristic ‘Weak to Absent’ INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas , 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[6]  Kevin B. Jones,et al.  β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition , 2015, Oncotarget.

[7]  Krystal M. Straessler,et al.  Modeling alveolar soft part sarcomagenesis in the mouse: a role for lactate in the tumor microenvironment. , 2014, Cancer cell.

[8]  Tsuyoshi Saito.  The SYT-SSX fusion protein and histological epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling. , 2013, International journal of clinical and experimental pathology.

[9]  G. Crabtree,et al.  Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma , 2013, Cell.

[10]  K. Woltjen,et al.  Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells. , 2013, Biochemical and biophysical research communications.

[11]  C. Fletcher,et al.  WHO classification of tumours of soft tissue and bone , 2013 .

[12]  F. Uher,et al.  Combined introduction of Bmi-1 and hTERT immortalizes human adipose tissue-derived stromal cells with low risk of transformation. , 2012, Biochemical and biophysical research communications.

[13]  A. Llombart‐Bosch,et al.  Immunohistochemical study of correlation between histologic subtype and expression of epithelial-mesenchymal transition-related proteins in synovial sarcomas. , 2011, Archives of pathology & laboratory medicine.

[14]  Kevin B. Jones,et al.  Of mice and men: opportunities to use genetically engineered mouse models of synovial sarcoma for preclinical cancer therapeutic evaluation. , 2011, Cancer control : journal of the Moffitt Cancer Center.

[15]  P. Provero,et al.  Epigenetic Features of Human Mesenchymal Stem Cells Determine Their Permissiveness for Induction of Relevant Transcriptional Changes by SYT-SSX1 , 2009, PloS one.

[16]  R. Kodet,et al.  Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma. , 2009, Cancer genetics and cytogenetics.

[17]  M. Hockin,et al.  A CreER-based random induction strategy for modeling translocation-associated sarcomas in mice. , 2009, Cancer research.

[18]  M. Capecchi,et al.  Synovial Sarcoma: From Genetics to Genetic-based Animal Modeling , 2008, Clinical orthopaedics and related research.

[19]  J. Goldblum,et al.  Immunostaining for SYT protein discriminates synovial sarcoma from other soft tissue tumors: analysis of 146 cases , 2007, Modern Pathology.

[20]  Malay Haldar,et al.  A conditional mouse model of synovial sarcoma: insights into a myogenic origin. , 2007, Cancer cell.

[21]  Marc Ladanyi,et al.  TLE1 as a Diagnostic Immunohistochemical Marker for Synovial Sarcoma Emerging From Gene Expression Profiling Studies , 2007, The American journal of surgical pathology.

[22]  A. Llombart‐Bosch,et al.  Mutational Analysis of the c-KIT AND PDGFRα in a Series of Molecularly Well-Characterized Synovial Sarcomas , 2005, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[23]  H. Sonobe,et al.  Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2α , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Sonobe,et al.  Detection of SYT-SSX Fusion Gene in Peripheral Blood From a Patient With Synovial Sarcoma , 2001, The American journal of surgical pathology.

[25]  C. Cooper,et al.  Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma , 1994, Nature Genetics.